Medical Research News

Nursing

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Gabriele JM et al. - Atypical antipsychotic treatment is associated with weight gain and increased metabolic risk. The information will be useful in determining what types of interventions are both effective and practical for delivery in health care or community mental health settings.

Related Articles

Use Of Antipsychotic Medications By Children And Adolescents Associated With Significant Weight Gain
Internet Source, 10/29/09    Relevance Score: 81%

Antipsychotics cause rapid weight gain in youth
Reuters, 10/28/09    Relevance Score: 80%

Metabolic and Cardiac Side Effects of Second-generation Antipsychotics: What Every Clinician Should Know
Journal of Pharmacy Practice, 11/05/09    Relevance Score: 79%

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/29/09    Relevance Score: 79%

Aripiprazole versus other atypical antipsychotics for schizophrenia
Cochrane Reviews, 10/21/09    Relevance Score: 78%

Today in Endocrinology...keeping you current

Is the use of resveratrol in the treatment and prevention of obesity premature?
Nutrition Research Reviews, 12/15/09

Comorbidity Affects the Relationship Between Glycemic Control and Cardiovascular Outcomes in Diabetes
Annals of Internal Medicine, 12/15/09

Effect of Obesity on Platelet Reactivity and Response to Low-Dose Aspirin
Preventive Cardiology, 12/15/09